Found 37 matching trials
A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma PHASE4 This Phase IV study is an a multi-centre, randomised open label, two way cr...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD. PHASE4 The purpose of this study is to investigate the effect of combined treatmen...
Show More Learn More & Join Trial
Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With Asthma PHASE3 This study is conducted to assess whether training participants on proper u...
Show More Location
Teva Investigational Site 34092
Learn More & Join Trial
ARrest RESpiraTory Failure From PNEUMONIA PHASE3 This research study seeks to establish the effectiveness of a combination o...
Show More Location
University of Alabama Birmingham - Main & Highlands
Learn More & Join Trial
Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04431AM2)(COMPLETED) PHASE3 This is a randomized, multicenter, double blind, parallel-group study evalu...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Investigate the Differential Effects of Inhaled Symbicort and Advair on Lung Microbiota PHASE2 This study will evaluate the effects of budesonide (using Symbicort which i...
Show More Location
St. Paul's Hospital
Learn More & Join Trial
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) PHASE4 The primary purpose of this study is to evaluate lung function and health r...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease PHASE3 The study is intended to characterize the lung function profile of BI1744 i...
Show More Location
1222.25.25009 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients PHASE3 The primary objective will be to compare the impact of the study formulatio...
Show More Location
IMA Brasil - Instituto de Pesquisa Clínica e Medicina Avançada
Learn More & Join Trial
Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) Patients PHASE3 The primary purpose of the study is to investigate if Symbicort is more eff...
Show More Learn More & Join Trial